1. Academic Validation
  2. Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities

Proteases and Their Modulators in Cancer Therapy: Challenges and Opportunities

  • J Med Chem. 2021 Mar 25;64(6):2851-2877. doi: 10.1021/acs.jmedchem.0c01640.
Rao Song 1 Wenliang Qiao 2 Jun He 1 Jiasheng Huang 1 Youfu Luo 1 Tao Yang 1 3
Affiliations

Affiliations

  • 1 State Key Laboratory of Biotherapy and Cancer Center/Collaborative Innovation Center for Biotherapy, West China Hospital, Sichuan University, Chengdu 610041, China.
  • 2 Lung Cancer Center, Laboratory of Lung Cancer, West China Medical School, Sichuan University, Chengdu 610041, China.
  • 3 Laboratory of Human Disease and Immunotherapies, West China Hospital, Sichuan University, Chengdu 610041, China.
Abstract

Proteostasis is the process of regulating intracellular proteins to maintain the balance of the cell proteome, which is crucial for Cancer cell survival. Several proteases located in the cytoplasm, mitochondria, lysosome, and extracellular environment have been identified as potential antitumor targets because of their involvement in proteostasis. Although the discovery of small-molecule inhibitors targeting proteases faces particular challenges, rapid advances in chemical biology and structural biology, and the new technology of drug discovery have facilitated the development of promising protease modulators. In this review, the protein structure and function of important tumor-related proteases and their inhibitors are presented. We also provide a prospective on advances and the outlook of new drug strategies that target these proteases.

Figures